Chief People and Communications Officer · SUTRO BIOPHARMA, INC. (STRO)

Linda Fitzpatrick

A named executive officer of SUTRO BIOPHARMA in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,303,734

Salary $381,900Stock awards $332,970Bonus $25,000

FY2019: $713,088

2nd of 4 named executive officers at Sutro Biopharma by FY2020 total.

4 named officers on file for SUTRO BIOPHARMA, FY2020

Linda Fitzpatrick’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • STRO’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how SUTRO BIOPHARMA’s whole pay program stands against its peers

  • SUTRO BIOPHARMA’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on STRO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2021 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Linda Fitzpatrick’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Linda Fitzpatrick compensation by year

SUTRO BIOPHARMA Summary Compensation Table · all 2 fiscal years held
In US dollars, as SUTRO BIOPHARMA reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$370,800$381,900
Bonus—$25,000
Stock awards$0$332,970
Option awards$208,800$374,975
Non-equity incentive$133,488$175,674
Pension and deferred compensation$0$0
All other$0$13,215
Total$713,088$1,303,734

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: SUTRO BIOPHARMA, INC. DEF 14A filed April 29, 2021, accession 0001564590-21-022043, and prior-year filings. Open the filing on EDGAR.

How this page was built: the SUTRO BIOPHARMA, INC. filed document, accession 0001564590-21-022043. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2021.

$713K
$1.3M
FY19
FY20
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU33,000$332,970—
RSU7,576$83,336—
Option10,644—$10.09
Option40,424—$10.09
Option625—$10.45
Option15,000—$10.45
Option13,332—$15.00
Option46,327—$15.00

Per the Outstanding Equity Awards at Fiscal Year-End table in SUTRO BIOPHARMA, INC.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

20 Form 4 lines since the FY2020 proxy (filed April 29, 2021)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2025-05-01Exercise or conversion—9,125$0.00104,558
2025-05-01Tax withholding—13,538$1.07119,744
2025-05-01Exercise or conversion—9,740$0.00114,298
2025-05-01Exercise or conversion derivative—9,125$0.000
2025-05-01Exercise or conversion—13,140$0.00127,438
2025-05-01Exercise or conversion—5,844$0.00133,282
2025-05-01Exercise or conversion derivative—13,140$0.0014,685
2025-05-01Exercise or conversion derivative—9,740$0.004,010

The 8 most recent of 20 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

SUTRO BIOPHARMA’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
William NewellChief Executive Officer$2,155,502
Linda Fitzpatrick · this pageChief People and Communications Officer$1,303,734
Trevor HallamChief Scientific Officer$1,241,270
Arturo MolinaM.S., FACP, Chief Medical Officer$1,174,717

The full SUTRO BIOPHARMA compensation record

free company brief

This page is one person within SUTRO BIOPHARMA's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the SUTRO BIOPHARMA proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are SUTRO BIOPHARMA's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Linda Fitzpatrick's compensation dossier · One-time report. No refunds.